Plenary Sessions

<English>

(1) “Futurablity” of Therapeutic Strategy of Heart Failure

Chairperson: Yasushi Sakata (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine)
Mark S. Slaughter (University of Louisville, USA)

Heart failure is a syndrome that includes signs and symptoms of congestion and low organ perfusion. What is "futurability," in other words, the possibility of treatment with heart failure in the future?

  1. Regulation of myocytes: Heart function is mainly determined by myocytes. Myocytes never divide but work for a long time. It remains unknown why myocytes have such unique characters. Elucidating these mechanisms is necessary.
  2. Regulation of organ-association: Heart failure is a systemic disorder. Cardiovascular disease is associated with many organ damages such as renal failure and liver dysfunction. These associations will be important therapeutic targets.
  3. Fusion of Technology: Recent progress in technology and bioengineering makes mechanical support easier than before. However, more progress is necessary for total replacement of heart.

This session hopes challenging and game-changing contents for the future possibility of treatment of heart failure.

close